Skip to main content
U.S. flag

An official website of the United States government

Nonsteroidal anti-inflammatory drugs in raptors

January 1, 2012

The use of analgesia has become standard, and appropriate, practice in avian medicine. As in mammals, pain control in avian patients is usually accomplished with opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) used singly or in combination for a multimodal approach. Despite their usefulness, widespread use, and relative safety in clinical use, few controlled studies in birds have been conducted on efficacy, safety, and dosing. The guidelines for the use of NSAIDs in raptors and other birds have mainly been empirical. More recently, NSAIDs in free-living raptors have emerged as a major conservation issue with the discovery that diclofenac sodium was responsible for the population crash of three species of Gyps vultures in southern Asia. In this context, residues of veterinary NSAIDs in domestic animals are now considered environmental contaminants that can be significantly toxic to vultures and possibly other avian scavengers. Ironically, the disaster with Asian vultures has led to a considerable body of research on NSAIDs in raptors to the benefit of clinicians who now have scientific information available to help assess dosing, safety, toxicity, and pharmacokinetics of NSAIDs in their raptor patients.

Publication Year 2012
Title Nonsteroidal anti-inflammatory drugs in raptors
DOI 10.1016/B978-1-4377-1986-4.00046-9
Authors J. Lindsay Oaks, Carol U. Meteyer
Publication Type Book Chapter
Publication Subtype Book Chapter
Index ID 70004853
Record Source USGS Publications Warehouse
USGS Organization National Wildlife Health Center